Table 4.
Survival outcomes
| 3 year % | 5 year % | 5 year HR | 95% CI | p value | |
|---|---|---|---|---|---|
| Local recurrence free survival | |||||
| Overall | 81.0 | 77.1 | |||
| Low-risk pT1 | 76.7 | 75.2 | Ref | Ref | Ref |
| High-risk pT1 | 71.5 | 67.8 | 1.41 | 0.65–3.06 | 0.39 |
| Overall survival | |||||
| Overall | 91.1 | 82.0 | |||
| Low-risk pT1 | 93.4 | 82.7 | Ref | Ref | Ref |
| High-risk pT1 | 89.4 | 75.0 | 1.51 | 0.58–3.99 | 0.40 |
| Patients without local recurrence | 93.1 | 85.1 | Ref | Ref | Ref |
| Patients with local recurrence | 84.1 | 67.7 | 2.41 | 1.05–5.50 | 0.037 |
| Recurrences | |||||
| Normal surveillance with recurrence | 80.0 | 80.0 | Ref | Ref | Ref |
| Close surveillance with recurrence | 69.4 | 63.1 | 1.94 | 0.24–15.58 | 0.53 |